Full Length Research Paper
References
|
Baudon C, Parent du Châtelet I, Antona Denise, Freymuth F, Poujol I, Maine C, Lévy-Bruhl D (2011). Caractéristiques de l'épidémie de rougeole démarrée en France depuis 2008 : bilan des déclarations obligatoires pour les cas survenus jusqu'au 30 avril 2011. Bull Epidémiol Hebd 34:353-358. (French). |
|
|
Collèges des universitaires de maladies infectieuses et tropicales (2016). Maladie, Viroses respiratoires. Rougeole. Dans: ePILLY trop. Maladies infectieuses et tropicales pp. 655-658 (French). |
|
|
Doshi RH, Mukadi P, Shidi C, Mulumba A, Hoff NA, Gerber, S, Okitolonda-Wemakoy E, Ilunga BK, Muyembe JJ, Rimoin AW (2015). Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo. Vaccine 33(29):3407-3414. |
|
|
Durrheim DN, Crowcroft NS (2017). The price of delaying measles eradication. The Lancet Public health 2(3):130-131. |
|
|
Fanny C (2014). Ebola et la faillite de la santé publique en Afrique », Revue Internationale Et Stratégique 96(4):18-27. (French). |
|
|
Guerra FM, Bolotin S, Lim G, Heffernan, J, Deeks SL, Li Y, Crowcroft NS (2017). The basic reproduction number (R0) of measles: a systematic review. The Lancet. Infectious diseases 17(12):e420-e428. |
|
|
Helfand RF, Gary HE, Jr, Atkinson WL, Nordin JD, Keyserling HL, Bellini WJ (1998). Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Clinical and diagnostic laboratory immunology 5(2):135-138. |
|
|
Institut National de la Statistique (2014). Résultats définitifs du Recensement Général de la Population et de l'Habitat (RGPH) 2014 de Côte d'Ivoire. Institut National de la Statistique, Côte d'Ivoire, 4 décembre 2017. Population data.net. Atlas des populations et pays du monde. |
|
|
Ma R, Lu L, Suo L, Zhangzhu J, Chen M, Pang X (2019). Evaluation of the adequacy of measles laboratory diagnostic tests in the era of accelerating measles elimination in Beijing, China. Vaccine 37(29):3804-3809. |
|
|
Masresha BG, Luce R, Okeibunor J, Shibeshi ME, Kamadjeu R, Fall A (2018). Introduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region - Lessons Learnt. Journal of Immunological Sciences pp. 113-121. |
|
|
Ministère de la Santé et de l'Hygiène Publique (2014). Evolution du profil épidémiologique de la rougeole en Côte d'Ivoire. Direction de Coordination du Programme Elargi de Vaccination. Côte d'Ivoire (DCPEV). Côte d'Ivoire (French). |
|
|
Ministère de la santé et de l'Hygiène Publique (2015). Plan National de Développement Sanitaire 2016-2020. Côte d'Ivoire (French). |
|
|
Murray J, Cohen A (2017). Infectious Disease Surveillance. International Encyclopedia of Public Health. pp. 222-229. |
|
|
Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota PA, Goodson JL (2019). Progress Toward Regional Measles Elimination - Worldwide, 2000-2018. MMWR. Morbidity and mortality weekly report 68(48):1105-1111. |
|
|
Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, Litton P, Miller E (2002). Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 20(7-8):1134-1140. |
|
|
Plans-Rubió P (2012). Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Human vaccines & immunotherapeutics 8(2):184-188. |
|
|
Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A (2013). Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children. Archives of Iranian medicine 16(1):38-41. |
|
|
Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H (2011). Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes. Journal of tropical pediatrics 57(5):347-351. |
|
|
Watanabe A, Shimada T, Takahashi T, Arima Y, Kinoshita H, Saitoh T, Kanou K, Matsui T, Sunagawa T, Tanaka-Taya K, Oishi K (2019). Correlates of laboratory-confirmed measles in Japan, 2011-2015. Vaccine 37(13):1756-1762. |
|
|
World Health Organization (WHO) (2015). African regional guidelines for measles and rubella surveillance. |
|
|
World Health Organization (WHO) (2016). Situation report - 10 June 2016. Emergencies preparedness and response. |
|
|
World Health Organization (WHO) (2020). Measles and Rubella Surveillance Data. Immunization, Vaccines and Biologicals. |
|
|
World Health Organization (WHO) (2010). Technical Guidelines for Integrated Disease Surveillance and Response in the African Region. |
|
|
Yang W, Li J, Shaman J (2019). Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations. PLoS computational biology 15(2):e1006806. |
|
|
Zoma RL, Walldorf JA, Tarbangdo F, Patel JC, Diallo AO, Nkwenkeu SF, Kambou L, Nikiema M, Ouedraogo A, Bationo AB, Ouili R, Badolo H, Sawadogo G, Krishnaswamy A, Hatcher C, Hyde TB, Aké F, Novak RT, Wannemuehler K, Mirza I, Soeters HM (2019). Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso. The Journal of infectious diseases, 220(220 Suppl 4):S233-S243. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
